WHC is still in active development. Read this to understand our approach.
depiction of UUQMNUMQCIQDMZ-UHFFFAOYSA-N.svg
isomerdesign

Betahistine

Check on isomerdesign

drugmap

N-methyl-2-(pyridin-...

Check on drugmap

wiki

Betahistine

Check on wiki

Data

InChI: InChI=1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3

Synonyms: N-methyl-2-pyridin-2-ylethanamine, Betahistina, Betaistina [DCIT], 2-(2-METHYLAMINOETHYL)PYRIDINE, N-Methyl-2-pyridineethanamine, Sinmenier (free base), 2-Pyridineethanamine, N-methyl-,N-methyl-2-(2-pyridinyl)ethanamine, 2-(2-(Methylamino)ethyl)pyridine,Betahistine, Betahistina [INN-Spanish], Betahistinum [INN-Latin], 2-[2-(Methylamino)ethyl]pyridine, Vasomotal, methyl[2-(pyridin-2-yl)ethyl]amine, beta-Histine, Serc, Betahistine [INN:BAN], 5638-76-6, N-Methyl-2-pyridineethylamine, Serc base,2-(beta-Methylaminoethyl)pyridine, PT 9 base,betahistine, Betahistinum

Estimated data

Solubility: -0.305 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 62.5% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.